MICROBIOLOGICAL MONITORING OF PURULENT COMPLICATIONS IN CANCER PATIENTS
##article.numberofdownloads## 24
##article.numberofviews## 372
PDF (Русский)

Keywords

PURULENT COMPLICATIONS
CANCER PATIENTS
ANTIBIOTIC RESISTANCE

How to Cite

Khokhlova, O., Alabusheva, A., Kapshuk, D., Yeremeeva, O., Sergeeva, V., Dykhno, Y., Yeremina, Y., Potkina, N., Modestov, A., Bobrova, O., Peryanova, O., & Ямамото, Т. (2018). MICROBIOLOGICAL MONITORING OF PURULENT COMPLICATIONS IN CANCER PATIENTS. Voprosy Onkologii, 64(1), 121–125. https://doi.org/10.37469/0507-3758-2018-64-1-121-125

Abstract

Infectious complications in cancer patients are an important public health problem. The purpose of the work is microbiological monitoring of purulent complications in cancer patients for the period 2003-2015. 4209 specimens from oncological patients were examined. The bacteriological method of investigation and PCR were used. It was established that gramnegative microflora occupied one of the leading places in the occurrence of purulent complications. A significant role was played by non-fermenting gram-negative pathogens - 32.8% of the total number of clinically significant strains. The main pathogens were characterized by a high degree of resistance to antimicrobial drugs - the proportion of MDR was 23.33%, XDR - 28.33%. The main mechanism of resistance in enterobacteria was the production of beta-lactamase of extended action (81.0%) including in K.pneumoniae (87.5%), E.coli (60.0%). During the follow-up period the number of methicillin -resistant strains increased significantly: MRSA - up to 52.5%, MRSE - up to 72.0%.
https://doi.org/10.37469/0507-3758-2018-64-1-121-125
##article.numberofdownloads## 24
##article.numberofviews## 372
PDF (Русский)

References

Белоусова Т.А. Инфекционные осложнения в колоректальной хирургии//Вопросы онкологии. - 2012. - Т 58. - № 6. - С. 736-743.

Давыдов М.И., Дмитриева Н.В. Инфекции в онкологии. - М. Практическая медицина, 2009. - 472 с.

Локтионова О.В., Невольских А.А., Туркин О.И. Стратегия профилактики инфекционных осложнений при проведении хирургического вмешательства в онкологическом стационаре // Хирургия. - 2010. - № 10. - С. 69-77.

Akiyoshi Т., Ueno M., Fukunaga Y et al. Effect of body mass index on short-term outcomes of patients undergoing laparoscopic resection for colorectal cancer: a single institution experience in Japan // Surg. Laparosc. Endosc. Percutan. Tech. - 2011. - № 21 (6). - P 409-414.

Anderson D.J., Hartwig M.G., Pappas T. et al. Surgical volume and the risk of surgical site infection in community hospitals: size matters // Ann Surg. - 2008. - № 247. - P. 343-349.

Avritscher E.B., Cooksley C.D., Rolston K.V. et al. Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume // Support Care Cancer. - 2014. - № 22. - P 527-535.

Baden L.R., Bensinger W., Angarone M. et al. Prevention and treatment of cancer-related infections // J. Natl. Compr. Cancer Netw. - 2012. - № 10. - C. 14121445.

Rolston K.V., Nesher L., Tarrand J.T Current Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective Review // Infect. Dis. Ther. - 2014. - № 3. - P. 245-256.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2018